Valganciclovir Hydrochloride For Oral
Product manufactured by Actavis Pharma, Inc.
Indications and Purposes
| 1 Indications And Usage Valganciclovir Hydrochloride For Oral Solution Is A Deoxynucleoside Analogue Cytomegalovirus (Cmv) Dna Polymerase Inhibitor Indicated For: Pediatric Patients ( 1.2 ) Prevention Of Cmv Disease In Kidney And Heart Transplant Patients At High Risk 1.2 Pediatric Patients Prevention Of Cmv Disease: Valganciclovir Hydrochloride Is Indicated For The Prevention Of Cmv Disease In Kidney Transplant Patients (4 Months To 16 Years Of Age) And Heart Transplant Patients (1 Month To 16 Years Of Age) At High Risk [See Clinical Studies ( 14.2 )]. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Valganciclovir Hydrochloride |
|
ZINC1543916 |